Skip to content

The clinical effects of penetrating needle therapy for subjective tinnitus:A randomized, controlled clinical study

The clinical effects of penetrating needle therapy for subjective tinnitus:A randomized, controlled clinical study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000264
Enrollment
Unknown
Registered
2024-08-20
Start date
2024-09-01
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

subjective tinnitus

Interventions

the control group:the cognitive behavior therapy
treatment group:Penetrating needle therapy

Sponsors

Shasha Yang
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1) Meet the diagnostic criteria of primary subjective tinnitus with tinnitus as the main complaint conscious of unilateral or bilateral tinnitus with or without hearing loss; The average pure tone hearing threshold of the worst ear is PTA (0.512kHz4kHz) ?65 dB; 2) Have good compliance age 18-75 years old gender is not limited; 3) Duration of tinnitus > 3 months; 4) Have not received tinnitus related treatment for nearly 1 week; 5) Willing to accept acupuncture treatment and able to complete the tinnitus assessment scale; 6) Sign informed consent voluntarily.

Exclusion criteria

Exclusion criteria: 1) Severe heart brain liver kidney and other organic diseases; 2) Bleeding tendency or abnormal coagulation mechanism; 3) Patients who cannot cooperate with treatment or have poor compliance; 4) Infection and severe allergic skin disease at the acupuncture site. 5) Pregnant or lactating women. 6) Lesions of the outer ear and middle ear; Objective tinnitus; Other lesions of the auditory system such as acoustic neuroma.

Design outcomes

Primary

MeasureTime frame
THI;VAS;TQ;

Secondary

MeasureTime frame
HAMA;HAMD;PISQ;

Countries

China

Contacts

Public ContactShasha Yang

The First Affiliated Hospital of Guizhou University of Chinese Medicine

yangyuansha88@163.com18286108233

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Sep 19, 2026